Charles Bonnet syndrome

  • Oliver Stojanov Deptartment of Ophthalmology, Health Center “Novi Sad”, Novi Sad, Serbia; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
Keywords: hallucinations, vision, ocular, macular degeneration, diagnostic techniques and procedures, diagnosis, differental,

Abstract


Introduction. Charles Bonnet syndrome (CBS) is a condition that causes visual hallucinations in patients without any mental illnesses. CBS is characterized by the presence of vivid, complex and recurrent visual hallucinations, and do not occur in the setting or as part of delirium or other psychological illnesses. The condition is present in patients who have visual loss due to age-related macular degeneration (AMD), cataracts and/or other ocular diseases that influence vision. Case report. A 81-year-od woman reported to ophthalmologist complaining of visual hallucinations that consisted of white pigeons. Hallucinations were present for two years and she was well aware that hallucinations were unreal. Mental illnesses were excluded by the psychiatrist. Complete ophthalmologic examination was performed, and finding revealed visual acuity of 0.3 (right eye) and 0.5 (left eye), in both eyes cataracts and AMD (wet form). Optical coherence tomography confirmed the fundoscopic finding of AMD. The patient rejected treatment of cataracts and AMD due to old age, and hallucinations persisted. Conclusion. CBS should be considered in patients with visual hallucinations and ocular diseases that influence vision. It is essential to distinguish CBS from mental illnesses, since patients with CBS are fully aware that hallucinations are not real. Awareness of CBS could help physicians upon referring patients to ophthalmologists instead of psychiatrists, and therefore avoid patients being misdiagnosed.

 

References

Schadlu AP, Schadlu R, Shepherd BJ. Charles Bonnet syndrome: a review. Curr Opin Ophthalmol 2009; 20(3): 219−22.

Kester EM. Charles Bonnet syndrome: case presentation and li-terature review. Optometry 2009; 80(7): 360−6.

Shiraishi Y, Terao T, Ibi K, Nakamura J, Tawara A. The rarity of Charles Bonnet syndrome. J Psychiatr Res 2004; 38(2): 207−13.

Singh A, Sørensen TL. The prevalence and clinical characteristics of Charles Bonnet Syndrome in Danish patients with neovas-cular age-related macular degeneration. Acta Ophthalmol 2012; 90(5): 476−80.

Menon JG, Rahman I, Menon SJ, Dutton GN. Complex visual hal-lucinations in the visually impaired: the Charles Bonnet Syn-drome. Surv Ophthalmol 2003; 48(1): 58−72.

Vukicevic M, Fitzmaurice K. Butterflies and black lacy patterns: the prevalence and characteristics of Charles Bonnet hallucina-tions in an Australian population. Clin Experiment Ophthal-mol 2008; 36(7): 659−65.

Santos-Bueso E, Sáenz-Francés F, Serrador-García M, Porta-Etessam J, Martínez de la Casa JM, García-Feijoo J, et al. Prevalence and clinical characteristics of Charles Bonnet syndrome in Madrid, Spain. Eur J Ophthalmol 2014; 24(6): 960−3.

Wilkinson F. Auras and other hallucinations: windows on the visual brain. Prog. Brain Res 2004; 144: 305−20.

Vale TC, Fernandes LC, Caramelli P. Charles Bonnet syndrome: characteristics of its visual hallucinations and differential diag-nosis. Arq Neuropsiquiatr 2014; 72(5): 333−6.

Rovner BW. The Charles Bonnet syndrome: a review of recent research. Curr Opin Ophthalmol 2006; 17(3): 275−7.

Madill SA, Ffytche DH. Charles Bonnet syndrome in patients with glaucoma and good acuity. Br J Ophthalmol 2005; 89(6): 785−6.

Jan T, del Castillo J. Visual hallucinations: charles bonnet syn-drome. West J Emerg Med 2012; 13(6): 544−7.

Zerilli-Zavgorodni T, Bisighini S. Charles Bonnet Syndrome: Comprehensive Review Providing an Optometric Approach to Diagnosis and Management. Optom Vis Perf 2014; 2(1): 26−38.

Doane J, Stults B. Visual Hallucinations Related to Angiotensin-Converting Enzyme Inhibitor Use: Case Reports and Review. J Clin Hypertens (Greenwich) 2013; 15(4): 230−3.

Roever CP, Vyas BB, Barnett MC, Sheyner I, Stewart JT. Visual Hallucinations in Long-Term Care. Ann Long Term Care 2012; 20(2): 25−30.

Hartney KE, Catalano G, Catalano MC. Charles Bonnet syn-drome: are medications necessary. J Psychiatr Pract 2011; 17(2): 137−41.

Published
2017/03/10
Section
Case report